Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition.
Lipinski B, Unmuth L, Arras P, Becker S, Bauer C, Toleikis L, Krah S, Doerner A, Yanakieva D, Boje AS, Klausz K, Peipp M, Siegmund V, Evers A, Kolmar H, Pekar L, Zielonka S.
Lipinski B, et al. Among authors: arras p.
MAbs. 2023 Jan-Dec;15(1):2236265. doi: 10.1080/19420862.2023.2236265.
MAbs. 2023.
PMID: 37469014
Free PMC article.